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ABSTRACT OF THE DISSERTATION
Influence of Gender and Training Background on Effect of Exercise on Adiponectin
by
Pooja Pratap Mujumdar
Doctor of Philosophy, Graduate Program in Pharmacology
Loma Linda University, June 2011
Dr. David Hessinger, Chairperson
Adipose tissue secretes the adipokine, adiponectin (ADPN), which is insulinsensitizing, anti-inflammatory, and anti-atherogenic. Exercise training improves insulin
sensitivity and lowers the risk of cardiovascular complications. As some of the metabolic
effects of exercise training and ADPN overlap, exercise training has been proposed to
increase ADPN. However, most single bout exercise, or short-term (3 months) and
constant-effort (fixed session duration, fixed number of sessions/week, and fixed
intensity) exercise protocols do not produce increases in ADPN in untrained and trained
cohorts. Furthermore, most exercise studies were conducted on male-female mixed
gender cohorts or male/female single gender cohorts. As a result, no direct comparison of
male and female subjects pertaining to the effect of exercise on ADPN levels has been
reported. Our governing hypothesis is that long-term aerobic exercise increases ADPN,
and the increase in ADPN is influenced by gender and exercise training background. We
tested two specific hypotheses using different cohorts of human volunteers. Hypothesis 1
states that ADPN levels will increase significantly in previously untrained, middle-aged
males and females in response to a long-term, progressive aerobic training protocol.
Hypothesis 2 states that ADPN levels in multi-year trained female marathoners will
increase significantly in response to a long-term, progressive aerobic training, but not in
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comparably trained males. We compared ADPN levels in trained marathoner males
(n=10) and females (n=8) subjects and untrained males (n=9) and females (n=11)
subjects in a 6-mo aerobic training intervention study. Fasting plasma samples were
collected at the beginning and end of the 6-mo training period and analyzed. ADPN
levels increased significantly in both trained and untrained females and untrained males,
but non-significantly in trained males. Ours is the first study to compare changes in
ADPN in mean age and BMI-matched male and female groups with two non-overlapping
exercise training backgrounds in response to the same long-term, progressive aerobic
training. The insight provided by the results of the two studies will help in understanding
gender differences in ADPN.

xii

CHAPTER ONE
INTRODUCTION

Obesity… The Much Talked about Issue!
Obesity has currently become a worldwide public health issue in many developed and
developing countries among people of all age groups. Increased caloric intake coupled
with decreased physical exercise results in obesity. Obesity greatly increases the
possibility of developing metabolic complications such as hypertension, atherosclerosis,
dyslipidemia, and insulin resistance (IR) that later lead to type II diabetes (DM2). An
estimated 24 million children and adult Americans have DM2; another 60 million people
have the pre-diabetic condition of high blood sugar [1], increasing their risk for
developing the disease. The American Diabetes Association estimates the cost of DM2 to
be at least $174 billion a year as of 2007 [1].

What is Adiponectin and Why Should We Care for It?
Adipose tissue, in addition to its function as a major energy store, is now known
to function as an active endocrine tissue that secretes several hormone-like proteins
termed adipokines. New adipokines are being discovered, but the current list of
adipokines includes chemerin, interleukin-6 (IL-6), plasminogen activator inhibitor-1
(PAI-1), retinol binding protein 4, tumor necrosis factor-alpha (TNF ), visfatin, leptin,
and adiponectin. Adipokines regulate satiety, lipid and carbohydrate metabolism, and
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insulin sensitivity [2, 3]. Decreased insulin sensitivity [or insulin resistance (IR)] involves
excessive insulin secretion in response to elevated blood glucose [3].
Mature adipocytes from visceral fat release an anti-inflammatory, insulinsensitizing adipokine, adiponectin (ADPN) [4]. ADPN antagonizes the inflammatory
effects of pro-inflammatory adipokines, IL-6 and TNF- and the levels of IL-6 and TNFare inversely related to ADPN levels [5]. ADPN stimulates free fatty acid (FFA)
oxidation in skeletal muscle [6] and ADPN levels positively correlate with circulating
FFA concentration [7]. ADPN levels are significantly lower in overweight, obese,
insulin-resistant, and diabetic individuals compared to lean or normal-weight individuals
[6]. Females have higher basal levels of ADPN than males [8]. Non-Hispanic whites
(Caucasians) have higher ADPN levels compared to other ethnic groups, such as nonHispanic blacks, Asians, and Hispanics [9]. The prevalence of DM2 is higher in all
populations other than non-Hispanic whites [10].

Aerobic and Resistance Exercise and Adiponectin,
and The Possible Mechanism of Interaction
Aerobic exercise helps maintain healthy levels of body fat, decreases IR,
improves DM2, and lowers the risk of developing cardiovascular complications [11].
Aerobic exercise has been at the forefront of life-style efforts to manage pre-diabetes and
diabetes. The mechanism by which aerobic exercise brings about favorable changes in
blood insulin and glucose levels is not yet known, but studies have noted the “antiinflammatory nature” of exercise [11].
Metabolic effects of aerobic exercise include reduction in body weight and body
fat, improved insulin sensitivity, improved cardiovascular health by improving plasma
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lipoprotein profile, reducing blood pressure, and decreasing incidences or preventing the
development of DM2 [11]. The reported metabolic effects of ADPN are: reduction of IR;
increase FFA oxidation; decrease hepatic glucose production by inhibiting enzymes of
gluconeogenesis; produce nitric oxide (NO) and improve endothelium-dependent
vasodilation; and reduce in thrombus formation and platelet aggregation [12]. Because
some of the metabolic effects of exercise training are similar to the effects of ADPN,
aerobic exercise training has been proposed to increase ADPN [11]. Since the discovery
of ADPN, studies have been conducted in human and rodent models to understand the
connection between aerobic exercise training and ADPN levels [13-15]. Several human
studies report that aerobic exercise increases [16-19] or does not increase [20-29] ADPN
levels. Differences in study outcomes are mainly due to differences in –
1. Cohort characteristics –
(i) Metabolic profile of the cohort (e.g. trained subjects/athletes [24, 30-32],
untrained normal-weight [22], untrained overweight [20, 26], untrained obese
[16, 27-29, 33], untrained insulin-resistant, DM2 subjects [16-19, 21])
(ii) Gender profile of the cohort (e.g. male-female combined [18, 19, 22, 23, 26,
27, 33, 34] or single gender male [24, 25, 29, 35] or female [17, 20] cohort)
2. Exercise intervention characteristics –
(i) Duration of exercise training intervention (e.g. short-term (i.e. 3 mos) [20, 21,
25, 27-29] or long-term (i.e. >3 mos) exercise studies [18, 19, 22-24, 26])
(ii) Nature of exercise training protocol (e.g. constant effort [22, 23, 26, 27, 33, 34]
or periodically increasing [progressive] protocol [18, 19, 35])
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Resistance/Strength training also has been shown to be helpful in managing of
DM2 by maintaining muscle mass [36]. Intervention studies employing resistance
training are fewer than aerobic exercise intervention studies and show increases [37-39]
and no changes [40-42] in ADPN. Similar to aerobic exercise interventions the
differences in the outcome of resistance training intervention also is due to
1. Cohort characteristics –
(i) Cohort metabolic profiles – studies were conducted on overweight, obese, or
DM2 subjects.
(ii) Gender profile of the cohort – studies were conducted on male only or female
only cohorts
2. Exercise intervention characteristics –
(i) Duration of exercise training intervention [e.g. short-term (i.e. 3 mos) [40-42]
or long-term (i.e. >3 mos) [37-39]].
(ii) Intensity of exercise training protocol [e.g. low-medium intensity (i.e. 80%
repetition maximum) [38, 40-42] or high intensity (i.e. >80% repetition
maximum [37, 38]].

Anticipated Mechanism and Gaps in The Literature
Some groups studying the effect of a long-term aerobic exercise on ADPN have
proposed that increases in ADPN levels might be due to the indirect reduction in total
body weight, mainly by reduction in body fat, or insulin resistance and not the direct
effect of the exercise intervention. It has been suggested that weight losses of more than
10% are necessary to detect significant increases in circulating ADPN [33]. Some
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researchers made similar observation where the obese females lost more than 10% body
weight through exercise intervention and showed a significant increase in ADPN [16,
17]. However, Ring-Dimitriou et al. found an increase in ADPN with less than 10%
decrease in body weight [18]. Some researchers found no increase in ADPN despite
decreases in body weight [26-28]. In a cross-sectional study, ADPN levels were higher in
physically active young adult females than in BMI- and age-matched sedentary females
[43]. Reduction in total body weight may not be necessarily associated with an increase
in ADPN.
In general, an inverse correlation exists between ADPN levels and body fat [6]. A
mean weight loss of 3% achieved by liposuction alone increased ADPN significantly in
obese women [44], thus reduction in body fat may increase ADPN levels. However, the
extent of body fat loss necessary to induce an increase in ADPN is not yet established.
During a 2-year exercise intervention, changes in levels of ADPN and body fat were not
inversely correlated [18] and a large (~44%) decrease in abdominal fat was not associated
with an increase in ADPN [21]. Reduction in body fat may not be necessarily associated
with an increase in ADPN.
The possibility of a dose-response effect of exercise on ADPN was raised by
studies where the intensity of aerobic exercise was varied [26]. Increasing levels of
resistance training were found to increase ADPN levels [38]. Increased intensity, as well
as increased duration of exercise increased ADPN in obese adolescent males [35].
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Gender Differences in Adiponectin Levels
Females, in general, exhibit higher ADPN levels than males [8]. This is primarily
due to a significantly higher concentration of the high molecular weight isoform in
females [8, 45]. Most long-term (>3 mos) exercise protocols studying the effect on
ADPN levels were conducted on combined cohorts of untrained males and females [18,
22, 23, 26, 34, 46] and only a few were conducted separately on male only [24, 35] or
female only cohorts [16, 17]. Independent of the duration of the intervention and
metabolic profile of the cohort, most aerobic exercise studies conducted solely with
males failed to show significant increases in ADPN levels [24, 25, 29], whereas those
with overweight and obese females showed increases in ADPN levels [16, 17, 19]. In a
two-year, moderate exercise training intervention on obese males and females RingDimitriou et al. [18] reported that the females showed twice the mean net increase in
ADPN compared to males at the end of 2-yr aerobic training. Long-term (>3 mos)
resistance training studies have also observed greater increases in ADPN levels of
females than males [37, 39]. Some researchers have raised a possibility that ADPN may
change differently in the two sexes due to exercise alone [17] or due to differences in
changes in body fat [46].

Significance of the Study
Exercise is at the forefront of DM2 treatment. Metabolic effects of exercise
include reduction in body weight and body fat, improved insulin sensitivity, and
improved cardiovascular health. Adiponectin (ADPN) is anti-inflammatory, insulinsensitizing, and anti-atherogenic. Because metabolic effects of exercise and ADPN
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overlap, exercise is proposed to increase ADPN. Higher levels of ADPN are noted in
athletes and centinarians. Females, in general, exhibit higher ADPN levels than males,
but the effect of aerobic training on ADPN levels in males and females has not been
compared. We studied the effect of long-term exercise training on ADPN in both
untrained and multi-year trained, weight-stable subjects to understand if ADPN increases
independently of body weight loss, exercise training conditioning, and gender. Our study
findings will help fill the gaps in gender-based effectiveness of exercise with reference to
ADPN levels.

Novelty of the Study Design
Females, in general, exhibit higher ADPN levels than males [8], but the effect of
aerobic training on ADPN levels in males and females has not been compared. Multi-year
trained male athletes have higher baseline ADPN levels than untrained controls [24, 31],
but the effect of aerobic training on ADPN levels of trained and untrained individuals has
not been compared. Several years of aerobic training reduces and stabilizes body weight,
body fat, and resting plasma insulin levels [31]. ADPN levels are significantly and
inversely correlated with body fat and resting plasma insulin levels [6]. Significant
increases in ADPN in presence [16, 17] and absence [26-28] of significant weight loss
have been reported, but changes in ADPN have not been compared in groups with and
without weight loss through the same exercise intervention. Most exercise intervention
studies did not control for changes in anthropometric measurements before interpreting
the changes in ADPN as a result of exercise intervention [14]. Hence no relationship
between weight reduction and changes in ADPN can be established. Our comprehensive
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hypothesis connects the established findings and assists in filling in the gaps left from
previous studies.
This dissertation endeavors to answer following questions to fill in the present
gaps in the literature 1. Does long-term aerobic training increase ADPN in healthy subjects?
Most of the studies in the literature have been conducted on overweight, obese, insulinresistant, DM2 subjects. Even though these studies showed an increase in ADPN, studies
conducted on healthy subjects showed no changes in ADPN.
2. Is weight loss necessary for an increase in ADPN?
The general opinion in the field is that a significant and more than 10% weight loss,
brought about by caloric restriction or aerobic exercise intervention or liposuction-type
weight reduction surgery procedures is essential for increases in ADPN levels. On the
other hand, some studies employing progressive training protocol showed increased
ADPN levels without significant weight loss. Many studies did not control for reductions
in weight, body fat, waist circumference to correctly interpret if intervention-induced,
specifically exercise intervention-induced increases in ADPN levels were due to
intervention alone or due to reductions in anthropometric measurements.
3. Are there gender differences in aerobic exercise-induced increases in ADPN?
Most studies were conducted on mixed gender male/female cohorts or male only female
only cohorts. Studies employing female only cohorts reported increases in ADPN while
most studies employing male only cohorts reported no changes. Ring-Dimitriou et al.
reported twice higher increase in ADPN in females compared to males [18]. No study
compared males and females through same exercise intervention.
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4. Are there training background-induced differences in increases in ADPN due
to aerobic exercise training?
Most studies were conducted on untrained subjects and only a few were conducted on
trained subjects. But no study compared changes in ADPN levels in trained and untrained
subjects undergoing same exercise training protocol. Do untrained subjects show higher
increases in ADPN levels as they are not conditioned to exercise training? Do trained
subjects show lesser increases in ADPN levels because they are conditioned to exercise
training? Our comprehensive study strives to answer these questions.

Hypothesis
We hypothesize that long-term aerobic exercise increases total circulating
adiponectin and that gender and exercise training background influence the exerciseinduced increase in adiponectin. Our governing hypothesis is based on several
observations reported in the literature. It also makes several predictions that, to our
knowledge, have not yet been tested. Our proposed study is designed to test the specific
aspects of our working hypothesis. We will test two specific hypotheses using different
cohorts of human volunteers.

Hypothesis 1
We hypothesize that ADPN levels will increase significantly in previously
untrained males and females in response to long-term, progressive aerobic training.
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Specific Aim 1
To compare ADPN levels before and at the end of a long-term, progressive
aerobic training regimen in middle-aged, untrained males and females. We will analyze
ADPN levels in both males (M) and females (F) from the untrained group that have never
trained for or participated in a full-distance (26.2 mile) marathon before. We will
measure markers of insulin-resistance and associated anthropometric parameters in
addition to ADPN levels.

Hypothesis 2
We hypothesize that ADPN levels in multi-year aerobic trained females will
increase significantly in response to long-term, progressive aerobic training, but not in
comparably trained males.

Specific Aim 2
To compare ADPN levels before and at the end of a long-term, progressive
aerobic training protocol in middle-aged, multi-year aerobic trained males and females.
We will analyze ADPN levels in both males (M) and females (F) from the trained
marathoner group that has been training for and completing at least one full-distance
(26.2 mile) marathon each year for five consecutive years. We will measure markers of
insulin-resistance and associated anthropometric parameters in addition to ADPN levels.
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Abstract
Adipose tissue secretes the adipokine, adiponectin (ADPN), which increases insulin
sensitivity. Because some of the metabolic effects of exercise and ADPN are similar,
exercise has been proposed to increase ADPN. However, most short-term (≤3 mos) and
constant-effort exercise protocols have not produced increases in ADPN. Furthermore, no
direct comparisons of male and female subjects on the effect of exercise on ADPN levels
have been reported. We hypothesized that long-term (6 mos), progressive training would
increase ADPN levels in both males and females. We recruited middle-aged, untrained
males and females to participate in an interventional study employing a marathon training
regimen progressing from 9.7 to 88.5 km (6 to 55 miles) per week over 6 mos. At
baseline, we matched the mean ages of the male and female groups. We collected and
stored fasting plasma samples and recorded body measurements at 0 (baseline) and 6
mos. Stored samples were analysed for insulin, glucose, and ADPN. ADPN increased
significantly among both males (from 5.89 ± 2.46 (mean ± SD) to 7.65 ± 3.18 μg/ml; p <
0.05) and females (from 8.48 ± 3.22 to 10.56 ± 4.05 μg/ml; p < 0.05). The extent of the
increase in ADPN was similar in the male (40.7 ± 50%; median, 12.1%) and female (27.0
± 31.1%; median, 22.3%) groups. However, there was no significant reduction in insulin
resistance as measured by the HOMA-IR scores in either group. We conclude that longterm, progressive aerobic training increases circulating ADPN levels in middle-aged,
untrained males and females.

Key Words
Exercise, intervention studies, human, adiponectin, sex differences
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Introduction
Adipose tissue, once thought to be exclusively a depot of fat, secretes several
hormone-like proteins termed adipokines. Adipokines regulate satiety, lipid and
carbohydrate metabolism, and insulin sensitivity. Decreased insulin sensitivity in the
form of insulin resistance involves excessive insulin secretion in response to elevated
blood glucose. Central obesity is on the rise in middle-aged men and women [1, 2] and
increased adipose mass decreases the production of adiponectin (ADPN), an adipokine
positively correlated with insulin sensitivity [3]. Mature adipocytes express and secrete
ADPN (aka gbp28, Acrp30, and apM1), which occurs in human plasma at concentrations
from 3 – 30 μg/ml. ADPN knockout mice on a high fat diet develop insulin resistance
and coronary artery disease [4] while ADPN over-expression improves insulin sensitivity
[5]. ADPN may preserve insulin sensitivity in middle-aged men and women [1, 2] since
ADPN levels negatively correlate with obesity, hypertension, type II diabetes,
hyperlipidemia, and metabolic syndrome [6].
Aerobic exercise improves insulin sensitivity, blood pressure, lipoprotein profile,
and metabolic and cardiovascular health [7]. Because some of these effects are similar to
some of the effects of ADPN, exercise has been proposed to increase ADPN [7]. Several
studies report that exercise increases [8 – 11] or does not increase [12 – 21] ADPN levels.
In general, studies employing short-term (i.e. ≤ 3 mos) exercise protocols showed nonsignificant changes in ADPN [12, 13, 17, 19 – 21]. Long-term (i.e.≤3 mos) exercise
studies on overweight, obese, or insulin-resistant subjects increased ADPN [8 – 11], but
not in normal-weight subjects [14,16]. In particular, long-term exercise studies
employing progressive protocols showed significant increases in ADPN [10, 11].
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However, most long-term protocols used combined male/female cohorts [10, 11, 14, 15,
18], but none have directly compared the effect of exercise in males and females using a
long-term, progressive aerobic protocol. We hypothesized that untrained, overweight,
middle-aged males and females would exhibit significant increases in ADPN in response
to a long-term, progressive aerobic protocol. To test our hypothesis, we compared the
effects of a progressive marathon-training program of 6 mos duration on ADPN levels in
untrained, age-matched males and females. We found that ADPN levels increased
significantly and to similar extents in both untrained males and females. This increase
was accompanied by a significant reduction in waist circumference in the male group and
by a significant reduction in body weight and hip circumference in the female group.

Methods
Subjects
We recruited subjects from a large (n ≈ 600) local running club to participate in a
6-mo, progressive, marathon running/walking program. The Institutional Review Board
of Loma Linda University approved the research protocol. At the planning stage of our
study, the local running club organizers informed us that in previous marathon training
programs conducted by the club, the female attrition rate was about twice that of males.
For this reason, we recruited more females than males. We presented the objectives and
procedures of the study to the club members. We gave interested members an informed
consent document explaining the procedures and risks and afforded opportunities to ask
questions. Potential subjects signed the informed consent document before completing a
screening questionnaire. Inclusion criteria were adult males and females who had never
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participated in or trained for a marathon. Exclusion criteria were known cardiovascular,
renal, hepatic, pulmonary, adrenal, pancreatic, thyroid, or pituitary disorder and smoking.
Demographic Characteristics
We separated the subjects into two groups: untrained males and untrained
females. At baseline, we age-matched the male and female groups by excluding ten
outlying female enrollees. The baseline cohort of males and females were numerically
similar in mean ages and BMI values (Table 2.1.).
During the 6 months of progressive training, our two groups exhibited different
rates of attrition over which we had little control. Males with the highest BMI values (i.e.
obese) dropped out to a greater extent than males of lower BMI categories, while females
of the next two lower BMI categories dropped out to a greater extent than obese females.
These opposing attrition trends caused the mean BMI values and ages of the two groups
to diverge slightly (compare Tables 2.1. and 2.2.).
The completing groups were not restricted to a particular ethnic group, but the
proportion of Caucasians to non-Caucasians in the study was similar between the male
and female groups with 36.4% and 22.2%, being Caucasians, respectively. We included
postmenopausal females both on (n = 1) and not on (n = 2) hormone replacement therapy
(HRT) because ADPN levels are reported to not differ between pre and postmenopausal
women nor between postmenopausal women on HRT and those not on HRT [22]. We
also included premenopausal females both on (n = 2) and not on (n = 6) oral
contraceptive pills because ADPN levels in females are reported to be stable throughout
the menstrual cycle [23], which we verified (data not showed). Female participants on
oral contraceptives or HRT continued to use these throughout the study.
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Table 2.1. Physical characteristics in male and female groups at the
baseline (0 mo).
Untrained Male
Untrained Female
(n=14)
(n=38)
Mean ± SD
Mean ± SD
Variable
p*
age
47.0 ± 13.8
44.6 ± 11.0
NS
HT
1.71 ± 0.03
1.63 ± 0.07
<0.0001
WT
81.8 ± 13.8
77.9 ± 15.6
NS
BMI
28.1 ± 4.7
29.4 ± 6.0
NS
BF
26.5 ± 9.0
37.7 ± 6.9
<0.0005
WST
98.4 ± 10.1
92.6 ± 13.1
NS
HIP
103.5 ± 12.7
108.9 ± 12.6
NS
WHR
0.96 ± 0.08
0.85 ± 0.07
<0.0005
Abbreviation key: WT, total body weight (kg); HT, height (m); BMI,
body mass index (kg/m2); WST, waist circumference (cm); HIP, hip
circumference (cm); WHR, waist-to-hip ratio; BF, total body fat (%);
NS, not significant; p*, significance between Untrained Male and
Female groups by independent t-test.
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Table 2.2. Physical characteristics and blood analytes in male and female groups at
the baseline (0 mo) and end (6 mos).
Abbreviation key: ADPN, plasma total adiponectin (μg/ml); FPI, fasting plasma insulin
(μU/ml); FPG, fasting plasma glucose (mg/dl); HOMAIR, HOmeostasis Model
Assessment of Insulin Resistance; WT, total body weight (kg); HT, height (m); BMI,
body mass index (kg/m2); WST, waist circumference (cm); HIP, hip circumference (cm);
WHR, waist-to-hip ratio; BF, total body fat (%); NS, not significant; LT, tests were
conducted on log transformed variable; p, significance within Untrained Male and
Female groups by paired t-test; †, effect of exercise training on ADPN levels between
Untrained Male and Female groups by repeated-measures ANOVA after controlling for
significant confounders; p*, significance between Untrained Male and Female groups by
independent t-test.
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Variable
age
HT
WT
BMI
BF
WST
HIP
WHR
ADPNLT
FPI
FPG
HOMA-IR

Time
0 mo
0 mo
0 mo
6 mo
p
0 mo
6 mo
p
0 mo
6 mo
p
0 mo
6 mo
p
0 mo
6 mo
p
0 mo
6 mo
p
0 mo
6 mo
p
0 mo
6 mo
p
0 mo
6 mo
p
0 mo
6 mo
p

Untrained Male
(n=9)
Mean ± SD
47.1 ± 12.2
1.72 ± 0.03
79.5 ± 9.2
78.2 ± 7.5
NS
26.8 ± 2.5
26.4 ± 2.1
NS
23.3 ± 4.8
23.8 ± 5.7
NS
96.7 ± 7.6
91.8 ± 7.4
<0.05
100.8 ± 6.6
99.0 ± 4.2
NS
0.96 ± 0.03
0.93 ± 0.06
NS
5.89 ± 2.46
7.65 ± 3.18
<0.05†
6.27 ± 3.48
5.47 ± 1.66
NS
93.6 ± 10.6
97.4 ± 14.3
NS
1.48 ± 0.88
1.32 ± 0.44
NS
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Untrained Female
(n=11)
Mean ± SD
43.2 ± 12.1
1.62 ± 0.07
79.7 ± 17.0
73.8 ± 13.4
<0.05
30.5 ± 7.2
28.3 ± 6.0
<0.05
38.1 ± 7.4
36.5 ± 6.9
NS
93.1 ± 13.0
88.0 ± 10.3
NS
110.3 ± 11.8
103.7 ± 8.4
<0.05
0.84 ± 0.08
0.85 ± 0.06
NS
8.48 ± 3.22
10.56 ± 4.05
<0.05†
8.97 ± 3.98
8.46 ± 4.57
NS
98.6 ± 5.4
96.0 ± 9.1
NS
2.21 ± 1.04
2.03 ± 1.12
NS

p*
NS
<0.005
NS
NS
NS
NS
<0.001
<0.001
NS
NS
<0.05
NS
<0.005
<0.05
NS
NS
NS
NS
NS
NS
NS
NS

Training Protocol
All subjects followed the same progressive training protocol for 6 mos (Figure
2.1.). The subjects met each Sunday at 7 a.m. with a pace group of their preferred speed
to complete the assigned weekly long-distance run (Figure 2.1.). Subjects also completed
additional progressive distances assigned for weekdays, but at times, days, and places of
their choosing. The Sunday distance increased linearly at an average rate of 1.16
km/week (km/week) from 3.2 to 32.2 km (2 to 20 miles). Weekday distance increased
non-linearly during the first 8 weeks (from 6.4 to 32.2 km) and thereafter increased
linearly at an average rate of 1.13 km/week (from 37 to 56.3 km) until the end of the
study period of 24 weeks (i.e. 6 mos). Total weekly distance increased non-linearly
during the first 8 weeks (from 9.7 to 45.1 km) and thereafter increased approximately
linearly at an average rate of 2.08 km/week (from 53.1 to 88.5 km) until the end of the
study (Figure 2.1.). We monitored adherence to the prescribed training protocol using
self-reported daily running logs, which were collected each Sunday. Subjects remained in
the same pace group throughout the study. We instructed subjects to maintain their preintervention dietary habits during the course of the study, but dietary intakes were not
monitored.
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Figure 2.1. Time course of long-term, progressive training protocol. Total weekly
distance ( ) is the sum of weekday distance (○) and Sunday distance (∆). Anthropometric
data and blood samples were collected at baseline (0 mo) and 6 mos as indicated by
arrows.
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Biochemical Measurements
We collected fasting blood samples on Sundays, immediately before the start of
the 3.2- and 32.2-km (2- and 20-mile), long-run distances corresponding to 0 and 6 mos,
respectively. We asked the subjects to avoid strenuous exercise 2 days before the blood
draws to avoid possible interfering pro-inflammatory cytokines [18]. We reminded the
subjects of the 12-h fast requirement by telephone contact the evening before the morning
blood draws. The 0-mo samples provided the baseline measurements, which also served
as each subject’s control. We collected blood samples between 6 and 7 a.m. to minimize
diurnal variation in ADPN levels [24]. A licensed phlebotomist drew venous blood from
the median antecubital vein into a 10-ml glass vacuum tube (0268384; BD, Franklin
Lakes, NJ) containing liquid K3 EDTA and protease inhibitor (250 KIU aprotinin /ml of
blood; Calbiochem, San Diego, CA) and immediately placed on ice. We collected plasma
within 1 h of blood collection by centrifuging at 1,900 x g in swinging buckets for 10 min
at 4°C, aliquoted plasma samples, and immediately stored them in cryogenic vials at
80°C until analysed. Before drawing the blood, we queried each subject about complying
with the fast and omitted those not found to comply. Subjects subsequently found to have
both fasting plasma insulin higher than 10 μU/ml and fasting plasma glucose higher than
110 mg/ml would have been determined to have broken the fast and would have been
excluded from the study. No subject exceeded the above-mentioned limits.
We used sandwich ELISA-based assays to measure fasting total plasma ADPN
(mg/ml; EZHADPN- 61K, LINCO Research, St. Charles, MO) and fasting plasma insulin
(FPI; μU/ml; EZHI-14K, LINCO Research) according to kit instructions. We measured
the absorbance in both assays at 450 nm on a plate reader (EL X 800, Universal
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microplate reader, BIOTEK Instruments Inc., Winooski, VT). We measured fasting
plasma glucose (FPG; mg/dl) using the glucose oxidase procedure (2810-1, Eagle
Diagnostics, De Soto, TX) according to kit instructions. We measured the absorbance at
500 nm. We measured the samples in duplicate, and re-assayed those with more than
10% variation from fresh aliquots. The average coefficient of variation using ELISA kits
for FPI assays was 3.9% (range: 3.2 – 4.4), for ADPN assays was 3.6% (range: 2.6 –
4.25), and for glucose assays was 1.2% (range: 0.8 – 1.7). We calculated the Homeostasis
Model Assessment of Insulin Resistance (HOMA-IR) scores using the following equation
[25]:
HOMA-IR = [FPI (μU/ml) X FPG (mg/dl)/18]/22.5

Anthropometric Measurements
Qualified personnel measured and recorded height (HT, m), body weight (WT,
kg), total body fat (BF, %), and waist circumference (WST, cm) and hip circumference
(HIP, cm) at 0 and 6 mos between 6 and 7 a.m. on the same day as the blood draw before
the long run on Sundays. Anthropometrics were measured with the subjects wearing light
running clothes without accessories and footwear. Waist circumference was recorded by
placing a tape measure evenly and snugly at the natural waistline in a standing position
where a waistline could be clearly identified. In the absence of such clearly identifiable
waistline, the waist circumference was measured by placing a tape measure halfway
between the top of the hip bone and the bottom of the rib cage. Hip circumference was
measured by placing the tape measure evenly and snugly over the widest area of the hips.
Waist-to-hip ratio (WHR) and body mass index (BMI) were calculated from the
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measurements. Height (m) was measured at baseline (0 mo) using a stadiometer. The
sliding part of the stadiometer was lowered so that the subject’s hair was pressed flat
against the scalp. Total body fat was measured on non-athletic/normal setting using
bioelectrical impedance (model: BF-679, TANITA Corporation, Arlington Heights, IL).
All measurements were obtained in duplicate, recorded, and averaged.

Statistical Analyses
We used the Statistical Package for Social Sciences (version 17.0) for Windows
(SPSS, Inc., Chicago, IL) to perform all statistical analyses. We considered the results
statistically significant if a two-tailed p -value was less than or equal to 0.05. We used
histograms and the Kolmogorov-Smirnov test for normality to determine whether the
variables for the study groups were normally distributed. We log transformed and
reassessed the variables that were not normally distributed. We used an independent t-test
to assess each dependent variable between the study groups separately for each data
collection point (i.e. 0-mo baseline and 6 mos). We also used an independent t-test to
assess percent changes in the variables between the groups. We used a paired t-test to
assess the difference in each dependent variable separately for each group when the
outcome was not controlled for potential confounders. We included potential confounders
as covariates in a multi-variable regression analysis using a repeated measure ANOVA to
control for the influence of changes in confounders on the outcome variable ADPN only.
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Results
Subject Compliance
We enrolled subjects meeting the inclusion and exclusion criteria. Cohort sizes at
each stage of the study are shown in Figure 2.2. Of the original 62 enrolled subjects,
retention among male subjects was almost three times as high (64%) as females (23%).
We carried out data analyses on a total of 20 subjects (i.e. males = 9; females = 11) who
completed the 6-mo training and provided complete data sets at baseline (0 mo) and 6
mos.
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127 assessed for eligibility

65 did not meet inclusion
criteria
Beginner Male

n = 14

n = 14

n=9

Beginner Female

Enrollment

n = 48

Baseline (0 mo) measurements

n = 38

Completed 6-mo training protocol
and End (6 mo) measurements

n = 11

Figure 2.2. Sample size and gender composition at each stage of the study.
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Adiponectin Levels
ADPN levels increased significantly at the end of 6 mos in both the male and
female groups. At baseline and at the end of 6 mos of training, the ADPN levels in the
female group were higher than those in the male group, but not significantly (Table 2.2.).
The percent change in ADPN (Δ ADPN %) was not significantly different between males
(40.7 ± 50.0%; median, 12.1%) and females (27.0 ± 31.1%; median, 22.3%). After
controlling for percent changes in WST and BMI using a repeated-measure ANOVA, the
effect of 6-mo exercise on ADPN levels of males and females was significant (p < 0.05,
Table 2.2., Figure 2.3.).
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Figure 2.3. Plasma adiponectin levels at baseline and end of 6 mos aerobic training in
groups identified by gender. Adiponectin levels (mean ± SEM) at the baseline (0 mo,
open bars) and end (6 mos, filled bars) were significant in males and females, as
determined by a repeated-measures ANOVA after controlling for percent change in
BMI and percent change in WST. Asterisk (*) indicates p < 0.05. Sample sizes of
each group are indicated in parentheses.
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Insulin, Glucose, and HOMA-IR Score
Male and female groups exhibited similar baseline and 6-mo FPI, FPG and
HOMA-IR score (Table 2.2.). Furthermore, FPI, FPG, and HOMA-IR score did not
change at the end of the 6 mos of training within either group.

Anthropometric Measurements
The male and female groups exhibited similar WT, BMI, and WST measurements
at the beginning and at the end of the study, however, the females had significantly
higher baseline HIP (Table 2.2.). BF among females was significantly higher than among
males at the beginning and at the end of the study. Males exhibited a significant 5%
reduction in WST (95% CI, -9.4 to -0.4), while WT, BMI, HIP, WHR decreased nonsignificantly and BF remained unchanged (Table 2.2.). Females exhibited a significant
7% reduction in WT and BMI (95% CI, -11.8 to -1.4), and a significant 6% reduction in
HIP (95% CI, -9.4 to -1.9). In females, the WST decreased by 5% (95% CI, -10.9 to 1.2)
and the BF by 3% (95% CI, -11.9 to 5.4), but not significantly, and the WHR remained
almost constant.

Discussion
In the present study, we compared the effects of long-term, progressive aerobic
exercise training on adiponectin (ADPN) levels between untrained, middle-aged men and
women. Previous studies have been mostly conducted on mixed male/female or singlegender cohorts. The influence of gender, if any, on changes in ADPN due to exercise has
not been studied. Our results show that long-term, progressive aerobic training
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significantly increases circulating levels of ADPN in untrained, middle-aged males and
females. These increases were accompanied by significant reductions in some body
measurements, but without changes in insulin resistance. The increase in ADPN levels
was similar in males and females.

Effects of Reductions in Anthropometrics
In the female group, we observed a 7% decrease in WT and BMI, a 6% decrease
in HIP, and a 5% decrease in WST. In the male group, we also observed only a 2%
decrease in WT, BMI, and HIP and a 5% decrease in WST. Because there were more
obese females than obese males, the decrease in WT in the female group was more than
in the male group. Compared to long-term studies [8 – 11] that employed obese, insulinresistant, or diabetic subjects, the anthropometric changes observed in our middle-aged,
untrained subjects were modest. The percent BF decreased non-significantly in both male
and female groups. The lack of correlation between changes in ADPN and changes in
body fat has been reported [10, 13]. The effect of exercise on ADPN levels cannot be
properly assessed unless controlled for concomitant anthropometric changes [26]. The
observed increases in ADPN in our male and female groups were significant after
adjusting for the percent changes in BMI and WST. Significant increases in ADPN levels
have been reported regardless of the extent of body weight loss [8 – 11, 27]. These and
our findings suggest that weight loss may not be necessarily associated with exerciseinduced increases in ADPN, although weight loss may be obligatorily associated with
increases in ADPN in dietary restriction studies [27]. In animal studies, ADPN levels are
regulated differently by diet restriction versus exercise [28].
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Effects of Gender
Females, in general, exhibit higher ADPN levels than males [29]. As stated
previously, most long-term (>3 mos) protocols studying the effects of exercise on ADPN
have been conducted on mixed male/female or single-gender cohorts [10, 11, 14, 15, 18,
30]. Long-term exercise interventions have shown increases in ADPN in females [8, 9],
but not in males [16]. Progressive exercise studies have shown increases in ADPN in a
mixed male/female cohort [11] and a male only cohort [10]. In our long-term, progressive
exercise study of untrained, middle-aged males and females, both gender groups
exhibited significant percent increases in ADPN. The present study was conducted on
subjects with no previous long-term, endurance training experience. The extent to which
different exercise training backgrounds play a role in gender-specific exercise-induced
changes in ADPN levels remains to be explored. Due to different rates of attrition in the
male and female groups, the difference in mean ages diverged from 2.4 years for baseline
groups (Table 2.1.) to 3.9 years for the completing groups (Table 2.2.). Differences in age
do not affect ADPN levels in females [31 – 33], but aging may increase ADPN levels in
normal-weight males over the age of 65 [34 – 35]. However, all of the males in our
cohort were under the age of 65. Hence, the mean age difference of 3.9 years between the
completing male and female groups is unlikely to significantly affect the comparability of
our study groups either in terms of ADPN levels or changes in ADPN levels. The issue of
whether the two groups are comparable is complicated by the fact that they are different
sexes. For example, the concept of BMI is not directly transportable between the two
sexes because of well known gender-based differences in bone mass and fat distribution.
In addition, it is well known that ADPN levels in females on average are higher than in
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males [24]. However, in terms of mean age, BMI, exercise history, and ethnicity, these
two groups are comparable for the main purpose of our study, which is to compare the
effects of 6 months aerobic training on changes in ADPN levels between untrained,
middle-aged males and females.

Effects of Insulin Resistance
Reported correlations between changes in insulin resistance and changes in
ADPN have been inconsistent. Some have shown that ADPN increases with improved
insulin sensitivity [36, 37]; others have shown that ADPN increases without improvement
in insulin sensitivity [15, 38]; and still others have shown no change in ADPN despite
improved insulin sensitivity [12, 13, 39]. In our 6-mo study, significant increases in
ADPN levels occurred in both the male and female groups without corresponding
reductions in HOMA-IR score, a surrogate measure of insulin resistance. Because insulin
sensitivity gradually decreases to control levels within 2 – 4 days after exercise [40, 41],
our subjects were asked to refrain from exercise 2 days prior to giving a blood sample.
Our findings suggest that exercise-induced increases in ADPN in untrained, middle-aged,
overweight males or females occur without changes in insulin sensitivity. Several factors
contributed to the relatively small sample size of our study. These were (i) the inclusion
of only untrained running club members, (ii) the exclusion of potential subjects on
prescription medicines influencing ADPN levels, and (iii) the contribution of long-term,
strenuous exercise intervention to injury-related dropouts, especially among the untrained
females.
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Conclusions
We conclude that long-term progressive aerobic training significantly increases
plasma ADPN levels in untrained, middle-aged, overweight males and females to similar
extents, but without significantly affecting insulin resistance. The significant reductions
in some anthropometric measurements, such as WT and WST, do not appear to influence
changes in ADPN. Thus, gender does not seem to significantly affect exercise-induced
increases in ADPN due to long-term progressive training in untrained, middle-aged,
overweight subjects.
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Abstract
Aerobic training and the adipokine, adiponectin (ADPN), both increase insulin
sensitivity. Because the metabolic effects of ADPN and aerobic training are similar,
aerobic training has been proposed to increase ADPN. Physically active adolescent
females show higher ADPN levels compared to sedentary controls. Long-term aerobic
training studies show greater increases in ADPN levels in untrained females than in
untrained males, and previously trained young males show no increase in ADPN levels.
Consequently, we hypothesized that long-term (6 months), progressive aerobic training
would increase ADPN levels in trained, middle-aged females, but not in comparably
trained males. We recruited aerobically trained, normal-weight, middle-aged males and
females to participate in a marathon training protocol progressing from 9.7 to 88.5 km (6
to 55 miles) per week over 6 months. We collected and stored fasting plasma samples and
recorded body measurements at 0 (baseline) and 6 months. Stored samples were analyzed
for insulin, glucose, and ADPN. ADPN increased significantly among females [from
18.37 ± 10.39 (mean ± SD) to 22.50 ± 9.87 µg/ml; P<0.05], but non-significantly among
males (from 6.69 ± 4.47 to 8.10 ± 5.57 µg/ml; P=0.2). No significant reduction in insulin
resistance or anthropometric measurements occurred in either group. We conclude that
long-term, progressive aerobic training increases circulating ADPN levels in trained,
middle-aged, normal-weight females, but not in comparable males.

Key Words
adiponectin, exercise, human, intervention studies, sex differences
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Introduction
Central obesity is on the rise in middle-aged men and women [1, 2] and increased
adipose mass decreases the production of adiponectin (ADPN), an adipokine positively
correlated with insulin sensitivity [3]. Mature adipocytes express and secrete ADPN (aka
gbp28, Acrp30, and apM1). ADPN knockout mice on a high fat diet develop insulin
resistance and coronary artery disease [4], while ADPN over-expression improves insulin
sensitivity [5]. Higher levels of ADPN may preserve insulin sensitivity in middle-aged
men and women [1, 2] since ADPN levels negatively correlate with obesity, high blood
pressure, type II diabetes, hyperlipidemia, and metabolic syndrome [6].
Aerobic exercise improves insulin sensitivity, blood pressure, lipoprotein profile,
and metabolic and cardiovascular health [7]. Because some of the effects of aerobic
exercise training and ADPN are similar, aerobic training has been proposed to increase
ADPN levels [7]. Cross-sectional studies reported significantly higher ADPN levels in
physically active versus sedentary adolescent females [8, 9].
At the end of a long-term [24 months (mos)] aerobic intervention involving
untrained, middle-aged, obese subjects, ADPN levels increased two-fold more in females
than in males [10]. Long-term (6 mos), progressive aerobic training also increased ADPN
levels almost twice as much (22.3%) in untrained, middle-aged, overweight females as in
untrained males (12.1%) [11], while long-term studies on young, elite male rowers
showed no changes in ADPN levels [12, 13]. Thus various studies indirectly suggest that
ADPN levels may increase more in physically active females than in males, but no study
has yet directly compared the effect of long-term aerobic training on ADPN levels in
trained males and females.
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We hypothesized that trained, normal-weight, middle-aged females would exhibit
significantly greater increases in ADPN in response to long-term, progressive aerobic
training than in similarly trained males. To test our hypothesis, we compared the effects
of a 6-mo, progressive, marathon-training program on ADPN levels in trained male and
female groups that were similar in baseline BMI and age. Consistent with our hypothesis,
we found that ADPN levels increased significantly in trained females by the end of 6-mo
training, but non-significantly in males.

Methods
Subjects
We recruited subjects from a large (n ≈ 600) local running club to participate in a
6-mo, progressive, marathon training program. The Institutional Review Board of Loma
Linda University approved the research protocol. We presented the objectives and
procedures of the study to the club members and gave interested members an informed
consent document explaining the procedures and risks and afforded opportunities to ask
questions. Potential subjects signed the informed consent document before completing a
screening questionnaire. Inclusion criteria were adult males and females that have been
training for and completing a minimum of one full-distance marathon per year for each of
the past five years. Exclusion criteria were known cardiovascular, renal, hepatic,
pulmonary, adrenal, pancreatic, thyroid, or pituitary disorder and smoking.
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Demographic Characteristics
We separated the subjects into two groups by gender: trained males and trained
females. As shown in Table 3.1., the male and female cohorts were similar in mean age
and mean BMI.
During the 6 mos of progressive training, the two groups exhibited similar rates of
attrition. However, because younger females dropped out to a greater extent than younger
males, the mean ages of the male and female groups diverged slightly, but not
significantly (compare Tables 3.1. and 3.2.). Several factors contributed to the relatively
small sample size of our study. These were (i) the inclusion of only middle-aged, multiyear trained running club members and (ii) the exclusion of potential subjects on
prescription medicines known to influence ADPN levels.
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Table 3.1. Physical characteristics in male and female
groups at the baseline (0 mo).
Trained Male Trained Female
(n=14)
(n=10)
Variable Mean ± SD Mean ± SD
p*
age
51.5 ± 11.1 54.9 ± 10.6
NS
HT
1.77 ± 0.05 1.63 ± 0.09 <0.001
WT
81.1 ± 12.8 63.3 ± 11.7 <0.005
BMI
25.8 ± 3.7
23.9 ± 3.5
NS
BF
22.5 ± 6.4
28.2 ± 8.1
NS
WST
93.1 ± 11.6 80.0 ± 13.1 <0.05
HIP
99.4 ± 7.7
98.9 ± 8.9
NS
WHR
0.94 ± 0.07 0.81 ± 0.09 <0.005
Abbreviation key: age (yr); HT, height (m); WT, total body
weight (kg); BMI, body mass index (kg/m2); BF, total body
fat (%); WST, waist circumference (cm); HIP, hip
circumference (cm); WHR, waist-to-hip ratio; NS, not
significant; p*, significance between Trained Male and
Trained Female groups by independent t-test.
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Table 3.2. Physical characteristics and blood analytes in trained male and female groups
at the baseline (0 mo) and end (6 mos).
Abbreviation key: age (yr); HT, height (m); WT, total body weight (kg); BMI, body mass
index (kg/m2); BF, total body fat (%); WST, waist circumference (cm); HIP, hip
circumference (cm); WHR, waist-to-hip ratio; ADPN, plasma total adiponectin (µg/ml);
FPI, fasting plasma insulin (µU/ml); FPG, fasting plasma glucose (mg/dl); HOMA-IR,
HOmeostasis Model Assessment of Insulin Resistance; NS, not significant; LT, tests were
conducted on log transformed variable; p, significance within Trained Male and Trained
Female groups by a paired t-test; p*, significance between Trained Male and Trained
Female groups by independent t-test.
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Variable
age
HT
WT
BMI
BF
WST
HIP
WHR
ADPNLT
FPI
FPG
HOMA-IR

Time
0 mo
0 mo
0 mo
6 mo
p
0 mo
6 mo
p
0 mo
6 mo
p
0 mo
6 mo
p
0 mo
6 mo
p
0 mo
6 mo
p
0 mo
6 mo
p
0 mo
6 mo
p
0 mo
6 mo
p
0 mo
6 mo
p

Trained Male
(n=10)
Mean ± SD
50.9 ± 11.5
1.75 ± 0.03
75.8 ± 9.6
75.4 ± 9.9
NS
24.9 ± 3.0
24.7 ± 3.1
NS
19.3 ± 7.7
19.2 ± 7.7
NS
86.7 ± 11.4
86.4 ± 11.2
NS
93.5 ± 11.3
93.0 ± 12.4
NS
0.93 ± 0.10
0.93 ± 0.09
NS
6.69 ± 4.47
8.10 ± 5.57
NS
5.69 ± 2.62
4.97 ± 2.94
NS
101.4 ± 30.2
97.9 ± 15.2
NS
1.43 ± 0.73
1.23 ± 0.79
NS
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Trained Female
(n=8)
Mean ± SD
58.8 ± 6.3
1.61 ± 0.08
63.4 ± 11.8
64.4 ± 12.6
NS
24.4 ± 3.5
24.8 ± 3.8
NS
30.9 ± 11.2
30.1 ± 8.1
NS
80.4 ± 14.1
79.5 ± 10.7
NS
99.1 ± 8.7
98.5 ± 9.3
NS
0.81 ± 0.10
0.81 ± 0.07
NS
18.37 ± 10.39
22.50 ± 9.87
<0.05
4.99 ± 3.63
5.11 ± 3.22
NS
101.7 ± 12.1
95.6 ± 17.4
NS
1.28 ± 1.00
1.25 ± 0.90
NS

p*
NS
<0.005
<0.05
0.06
NS
NS
<0.05
<0.05
NS
NS
NS
NS
<0.05
<0.005
<0.005
<0.005
NS
NS
NS
NS
NS
NS

Subjects were not restricted to a particular ethnic group, but the proportion of
Caucasians to non-Caucasians in the completing cohorts of the study were similar with
80.0% and 87.5%, being Caucasians in the male and female groups, respectively. We
included postmenopausal females both on (n=3) and not on (n=4) hormone replacement
therapy (HRT) because ADPN levels have been reported to not differ between
postmenopausal women on HRT and those not on HRT [14]. We also included two
premenopausal women, who did not complete the study, and a perimenopausal female
(age 53 yrs) on oral contraceptive (OC) because ADPN levels in females are reported to
be stable throughout the menstrual cycle [15, 16] and unaffected by the use of OCs [16].
The ADPN levels have also been reported to not differ between premenopausal women
not on OC and postmenopausal women not on HRT [14]. Female participants on oral
contraceptives or HRT continued to use these throughout the study.

Training Protocol
All subjects followed the same progressive training protocol for 6 mos, which is
described in detail elsewhere [11]. The Sunday distance increased linearly at an average
rate of 1.16 km/week (km/week) from 3.2 to 32.2 km (2 to 20 miles) over a period of 6
mos. Weekday and total weekly distances increased non-linearly during the first 8 weeks
and thereafter increased linearly until the end of 6 mos (Figure 3.1.). We monitored
adherence to the prescribed training protocol using self-reported daily running logs,
which were collected each Sunday. Subjects remained in the same pace group throughout
the study. We instructed subjects to maintain their pre-intervention dietary habits during
the course of the study, but dietary intakes were not monitored.
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Figure 3.1. Time course of long-term, progressive training protocol. Total weekly
distance () is the sum of weekday distance () and Sunday distance ().
Anthropometric data and blood samples were collected at baseline (0 mo) and 6 mos as
indicated by arrows.
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Biochemical Measurements
Biochemical measurements are described in detail elsewhere [11]. Briefly, we
collected fasting blood samples from the median cubital vein on Sundays, immediately
before the start of the 3.2- and 32.2-km (2- and 20-mile), long-run distances
corresponding to 0 and 6 mos, respectively. We collected plasma by centrifugation,
separated plasma samples into 0.5 ml aliquots, and immediately stored them at -80oC
until analyzed. We used spectrophotometric, sandwich ELISA-based assays for fasting
total plasma ADPN (mg/ml; EZHADPN-61K, LINCO Research, St. Charles, MO) and
fasting plasma insulin (FPI; µU/ml; EZHI-14K, LINCO Research) and the liquid oxidase
procedure (2810-1, Eagle Diagnostics, De Soto, TX) for fasting plasma glucose (FPG;
mg/dl). We calculated the HOmeostasis Model Assessment of Insulin Resistance
(HOMA-IR) scores using the following equation [17]: HOMA-IR = [FPI (µU/ml) x FPG
(mg/dl)/18]/22.5

Anthropometric Measurements
Qualified personnel measured and recorded height (HT, m), body weight (WT,
kg), total body fat (BF, %), waist circumference (WST, cm) and hip circumference (HIP,
cm) as previously described [11]. These measurements were taken at 0 and 6 mos
between 6-7 AM on the same day as the blood draw immediately before the long run on
Sunday. Waist-to-hip ratio (WHR) and body mass index (BMI) were calculated from the
measurements. Height (m) was measured at baseline (0 mo) using a stadiometer. Total
body fat was measured on standard adult mode (non-athlete mode) setting using
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bioelectrical impedance (model BF-679, TANITA Corporation, Arlington Heights, IL).
All measurements were obtained in duplicate, recorded, and averaged.

Statistical Analyses
We used the Statistical Package for Social Sciences (version 17.0) for Windows
(SPSS, Inc., Chicago, IL) to perform all statistical analyses. We considered the results
statistically significant if a two-tailed P-value was less than or equal to 0.05. We used
histograms and the Kolmogorov-Smirnov test for normality to determine whether the
variables for the study groups were normally distributed. We log transformed and
reassessed the variables that were not normally distributed. We used an independent t-test
to assess each dependent variable between the study groups separately for each data
collection point (i.e. 0-mo baseline and 6 mos). We also used an independent t-test to
assess percent changes in the variables between the groups. We used a paired t-test to
assess the difference in each dependent variable separately for each group.

Results
Subject Compliance
We enrolled subjects meeting the inclusion and exclusion criteria. Cohort sizes at
each stage of the study are diagramed in Figure 3.2. Of the original 27 enrolled subjects,
retention among trained male and trained female subjects was the same (66.7%). We
carried out data analyses on a total of 18 subjects (i.e. males = 10; females = 8) who
completed the 6-mo training and provided complete data sets at baseline (0 mo) and 6
mos.
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Adiponectin Levels
The levels of ADPN increased at the end of 6 mos of training in both male and
female groups, but significantly only among the trained females (Fig. 3.3.). In the female
group ADPN levels at the baseline and at the end of 6 mos of training were significantly
higher by three-fold than in the male group (Table 3.2.). The percent increases in ADPN
were not significantly different between males (22.0 ± 43.4%; median, 11.4%) and
females (38.7 ± 53.2%; median, 18.8%).

Insulin, Glucose, and HOMA-IR score
Trained male and female groups exhibited similar FPI and FPG levels and
HOMA-IR scores at baseline and at the end of the study (Table 3.2.). Furthermore, FPI
and FPG levels and HOMA-IR scores did not change by the end of the 6 mos of training
within either group.
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127 assessed for eligibility

100 did not meet inclusion
criteria
Trained Male

n = 15

Trained Female

Enrollment

n = 12

n = 14

Baseline (0 mo) measurements

n = 10

n = 10

Completed 6-mo training protocol
and End (6 mo) measurements

n=8

Figure 3.2. Sample size and gender composition at each stage of the study.
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30

Adiponectin (µg/ml)

*
20

10

0
Trained Male (n=10)

Trained Female (n=8)

Figure 3.3. Plasma adiponectin levels at baseline and at end of 6 mos aerobic training
in groups identified by gender. Increase in adiponectin levels (mean ± SEM) between
baseline (0 mo, open bars) and end (6 mos, filled bars) was significant in trained
females, but not trained males, as determined by a paired t-test. Asterisk (*) indicates
P<0.05. Sample sizes of each group are indicated in parentheses.
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Anthropometric Measurements
The trained males had higher WT than females. The difference was significant at
the baseline, but non-significant at the end of the 6-mo training. The male and female
groups exhibited similar BMI, WST, and HIP measurements at the baseline and at the
end of 6 mos training. The females had significantly higher BF and lower WHR
compared to males at the baseline and at the end of 6 mos training. (Table 3.2.).
Both males and females exhibited negligible and non-significant reductions in
mean WST and HIP, and negligible and non-significant increases in mean WHR and BF.
Additionally, males exhibited negligible reductions in WT and BMI, whereas females
exhibited negligible increases in WT and BMI (Table 3.2.).
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Discussion
In the present study, we compared the effects of long-term, progressive aerobic
training on adiponectin (ADPN) levels in trained male and female marathoners who were
middle-aged and normal-weight. Few exercise interventions measuring changes in ADPN
levels have been conducted on middle-aged athletes. Because previous studies have
mostly focused on trained, single-gender cohorts, the influence of gender on exerciseinduced changes in ADPN has not been adequately addressed. Our results show that
long-term, progressive aerobic training of 6 mos duration increases circulating levels of
ADPN to a significantly greater extent in trained, middle-aged females than in similarly
trained males.

Effects of Gender
Females, in general, exhibit higher ADPN levels than males [18]. In our previous
study on untrained, middle-aged subjects undergoing 6-mo, progressive aerobic training,
ADPN levels in females were slightly higher both at baseline and at 6 mos compared to
males, and both males and females showed significant and similar increases in ADPN
levels [11]. However, in the present study on trained, middle-aged marathoners, the malefemale differences in ADPN levels at baseline and at 6 mos were significantly larger with
the trained females exhibiting ADPN levels three times higher than the comparably
trained males. In addition, our 6-mo, aerobic protocol increased ADPN significantly in
trained females (P<0.05), but non-significantly (P=0.19) in trained males, which is
similar to a 6-mo study showing no significant increases in ADPN levels among young,
trained male rowers [13].

58

Aerobically exercising females derive proportionately more of their expended
energy from free fatty acid oxidation than do males [19, 20]. ADPN expression positively
correlates with hormone-sensitive lipase activity in females [21], which regulates
lipolysis in adipose tissue. Thus, our observation that trained exercising females exhibit
higher levels and greater increases in ADPN than comparably trained males may be
metabolically linked to trained females’ greater capacity to mobilize and use mobilized
free fatty acids to fuel their aerobic exercise.

Effects of Training History
When comparing ADPN levels between untrained subjects from our previous
study [11] and trained subjects from our current study, the baseline ADPN levels in the
trained males were not higher than those in the untrained males [11]. However, the
baseline ADPN levels in the trained females were twice those in the untrained females
[11]. Because of differences in mean age, BMI, and ethnicity between the cohorts of
these two studies, we cannot readily compare untrained and trained subjects from the
same gender. However, it appears that several years of prior aerobic training may
increase ADPN levels much more in females than in males.

Effects of Insulin Resistance
Aerobic training lowers resting levels of insulin [12]. However, we did not expect
the 6-mo training protocol to produce significant increases in insulin sensitivity because
our subjects already were trained and exhibited HOMA-IR scores indicative of healthy
insulin sensitivity at baseline. In fact, we did not observe any changes in insulin
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sensitivity following 6 mos of training. Our findings suggest that exercise-induced
increases in ADPN can occur without measurable reduction in HOMA-IR scores in
trained males and females.

Effects of Body Measurement Changes
Because all of our subjects were previously trained, we did not expect the 6-mo
aerobic training to produce significant changes in body measurements, nor did we
observe any. Elite male rowers also showed no changes in body weight in response to 6mo training [13]. Weight loss has been considered by some to be a necessary correlate to
increased ADPN levels [22-25]. However, studies using long-term aerobic training have
reported increases in ADPN levels without weight loss in untrained [10, 11, 26] and
trained subjects [12, 13]. These and our current findings with trained subjects suggest that
weight loss is not necessary for exercise-induced increases in ADPN.

Conclusions
We conclude that 6-mo, progressive, aerobic training increases circulating ADPN
levels in multi-year trained females to a larger extent than in similarly trained males. To
our knowledge, our findings are the first to show that only trained females benefit in
terms of increased ADPN levels by the additional training. In addition, our findings show
that exercise-induced increases in ADPN levels can occur in the absence of changes in
insulin-sensitivity or weight loss in previously trained individuals. Comparing the current
findings with those from our previous study on untrained subjects, it appears that males
on the one hand show little to no increase in ADPN levels beyond what occurs during 6
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mos of progressive training. On the other hand, ADPN levels in females increase beyond
6 mos of marathon training if aerobic training continues. Thus, the extent of exerciseinduced increase in ADPN levels appears to be gender-specific; limited in males, but
extended in females.
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CHAPTER FOUR
DISCUSSION/CONCLUSION

Goal of Dissertation
The overall goal of the dissertation was to elucidate the influence of gender and
aerobic training background on exercise-induced increase in adiponectin.
Our general hypothesis was that long-term aerobic training increases total
circulating adiponectin and that gender and exercise training background strongly
influence the extent of the exercise-induced increase in adiponectin.
The general hypothesis included two specific hypotheses –
In Hypothesis 1, we hypothesized that ADPN levels increase significantly in
previously untrained males and females in response to long-term, progressive aerobic
training. To test this hypothesis, our specific aim was To compare ADPN levels before
and at the end of a long-term, progressive aerobic training regimen in middle-aged,
untrained males and females. We measured ADPN levels in untrained male and female
subjects that had never trained for or participated in a full-distance (26.2 mile) marathon.
In addition to ADPN levels we measured markers of insulin-resistance and
anthropometric parameters.
In Hypothesis 2, we hypothesized that ADPN levels in multi-year aerobic trained
females increase significantly in response to long-term, progressive aerobic training, but
not in comparably trained males. To test this hypothesis, our specific aim was To
compare ADPN levels before and at the end of a long-term, progressive aerobic training
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regimen in middle-aged, multi-year aerobic trained males and females. We measured
ADPN levels in trained male and female subjects that have been training for and
completing at least one full-distance (26.2 mile) marathon each year for the five previous
consecutive years. We measured markers of insulin-resistance and anthropometric
parameters in addition to ADPN levels.

Major Findings of The Dissertation
Our study design and methodology achieved the goal of the project and we
conclude that gender and aerobic training background strongly influence exerciseinduced increases in ADPN. Our findings also show that exercise-induced increases in
ADPN levels can occur independently of insulin-sensitivity changes in both untrained
and trained subjects. In addition, we have shown that exercise-induced increases in
ADPN can occur independently of weight loss in both untrained and previously aerobictrained individuals. On the one hand, it appears that males, show little to no increase in
ADPN levels beyond that which occurs during 6 mos of progressive marathon training.
On the other hand, females show increased ADPN levels beyond 6 mos of marathon
training program if aerobic training continues. Thus, the extent of exercise-induced
increase in ADPN levels appears to be gender- and training background-specific with
ADPN levels increasing in males and reaching a plateau at relatively moderate levels of
training, while in females ADPN levels increase with increasing durations of training.
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Contributions to The Field
Our comprehensive study fills in the gaps in the literature by answering the
following questions:
1.

Does long-term aerobic training increase ADPN in healthy subjects?

Most of the studies in the literature have been conducted on overweight [1, 2],
obese [3-7], or insulin-resistant or DM2 subjects [3, 8-11]. Although these studies
showed an increase in ADPN, studies conducted on untrained and trained healthy
subjects showed no changes in ADPN [12, 13]. Our study showed a significant increase
in healthy untrained male and female subjects and healthy trained female subjects and a
weaker trend of increase P=0.19 in ADPN in healthy trained males. Therefore, we
conclude that long-term aerobic training does increase ADPN in healthy subjects.
2.

Is weight loss necessary for an increase in ADPN?

The general opinion in the field is that greater than 10% weight loss brought about
by caloric restriction, aerobic exercise intervention, and/or liposuction is needed to
increase ADPN levels [3, 7]. However, some studies employing progressive training
protocols showed increased ADPN levels without significant weight loss [9]. Many
studies that observed increased ADPN levels due to exercise training intervention did not
control for reductions in weight, body fat, waist circumference [3, 8, 9, 14, 15] to
correctly interpret if intervention-induced, specifically exercise intervention-induced,
increases in ADPN levels were due to intervention alone or due to reductions in
anthropometric measurements.
Our untrained male and female subjects showed a reduction in body weight and
waist circumference [16]. After statistically controlling for these changes in a repeated
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measure ANOVA, the increase in ADPN was still significant. The trained subjects in our
study showed no decrease in anthropometric measures, but the trained females showed a
significant increase in ADPN and the trained males showed a trend of increased (P=0.19)
ADPN levels at the end of 6-mo progressive aerobic training (submitted). Therefore, we
conclude that weight-loss is not a prerequisite for exercise-induced increases in ADPN.
3.

Does gender influence aerobic exercise-induced increase in ADPN?

Most studies were conducted on cohorts with male-female subjects together [1, 6,
7, 9, 10, 12, 14, 17] or male [4, 13, 15, 18] or female [2, 8] subjects. Studies employing
female-only cohorts reported increases in ADPN while most studies employing maleonly cohorts reported no changes. Ring-Dimitriou et al. reported two-times higher
increases in ADPN in females compared to males [9]. Until our two studies, no study had
compared males and females during same exercise intervention. Our untrained and
trained females showed a significant and two times greater increase in ADPN levels
compared to our untrained and trained males. Our untrained males showed a significant
increase in ADPN, but not the trained males. Therefore, we conclude that exerciseinduced increase in ADPN is gender specific.
4.

Is aerobic exercise-induced increase in ADPN affected by different

training backgrounds? Are there differences in aerobic exercise-induced increases
in ADPN in people with and without aerobic training background?
Most long-term exercise intervention studies have been conducted on untrained
subjects [1-11, 14, 15, 17-20] with only a few on trained subjects [13, 21]. No previous
study, however, compared changes in ADPN levels in trained and untrained subjects
undergoing the same exercise training protocol. Our comprehensive study sought to
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answer the question: Do untrained subjects show higher increases in ADPN levels, as
they have not been conditioned to exercise training? Our trained and untrained females
both showed similar (median, ~20%) increases in ADPN. Our trained and untrained
males also showed similar (median, ~10%) increases in ADPN. Therefore we conclude
that aerobic exercise-induced increase in ADPN does not differ according to training
background.

Assumptions and Limitations of The Study
Our study groups were based on self-reported information concerning the
subjects’ exercise training and medical history. The results of our studies should be
interpreted with attention to the following limitations –
1. Body composition –
We used the bioelectric impedance method (model: BF-679, TANITA
Corporation, Arlington Heights, IL) for measuring total body fat as a percent of total
body weight. This method does not give differential body fat measurement data
associated with different compartments of body fat, subcutaneous and visceral. Hence,
we could not associate the increase in ADPN levels with loss of a specific compartment
of fat, particularly visceral fat.
We measured body fat of both trained and untrained subjects using the standard
mode of the TANITA® model. According to our trial runs with the TANITA® model,
athlete mode understates the total body fat measurements whereas standard mode
overstates the total body fat measurements of a trained subject. To compare body fat
composition of the untrained group to that of the trained group, it was not advisable to
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measure the untrained subjects on the standard mode and the trained subjects on athlete
mode, as it would yield a much larger difference in the mean percent body fat of two
groups and introduce error.
2. Family medical history We did not record the family medical histories of our subjects for hypertension,
DM2, or cancer. Offspring of DM2 patients have lower circulating ADPN levels [22] as
compared to those without the family history of DM2. But short-term (7-weeks) aerobic
training reported similar increases in ADPN levels in the offspring of DM2 patients and
those without the family history of DM2 [23].
3. Intensity of exercise training –
VO2max is a measure of a subject’s aerobic capacity. Exercise studies also use
VO2max as a measure of intensity of exercise training. The scope of our training protocol
was not to improve the endurance capacity of subjects, but to train them to complete a
full-distance marathon. Our study measured the effect of increasing duration (distance) of
training, but not intensity of training, on changes in ADPN levels. We measured the
intensity of aerobic training as pace (minutes taken to complete a mile distance) of the
subject. Our subjects were instructed to follow the given training protocol and trained
independently, hence the best estimate of the intensity of their aerobic training was
determined by pace measurement. There were no significant differences in the pace at
baseline and at the end of 6 mos in the trained or untrained subjects.
4. Ethnic composition of the cohorts –
Non-Hispanic whites (Caucasians) have higher ADPN levels compared to other
ethnic groups, e.g. non-Hispanic blacks, Asians, and Hispanics [24]. Because our study
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measured changes in ADPN levels in response to the long-term aerobic training, we did
not restrict the study cohorts to a specific ethnic group. The effect of ethnicity, if any, on
the changes in ADPN levels due to exercise (aerobic or resistance) training have not been
noted. When we separated our subjects into two groups based on their ethnicity:
Caucasians and other-than-Caucasians, the ratio of Caucasians to other-than-Caucasians
was similar within each gender for the trained and untrained study cohorts. Thus,
ethnicity was not a likely confounding factor to the results of the study.
5. Menopausal status or day of menstrual cycle Our study included premenopausal women both on and not on oral contraceptives
and postmenopausal females both on and not on hormone replacement therapy (HRT).
ADPN levels do not differ between pre and postmenopausal women nor between
postmenopausal women on HRT and not on HRT [25]. We also included premenopausal
women both on and not on oral contraceptives because ADPN levels in females are
reported to be stable throughout the menstrual cycle implying that changes in estrogen
levels do not affect ADPN levels [26].
It has been noted that the luteal phase of the menstrual cycle is associated with
weight gain in women [62]. The weight gain is anticipated due to premenstrual increases
in appetite and eating and/or fluid retention [63]. The changes in appetite, water retention
and the resulting weight gain is reported to be minor [27] and higher for women using
monophasic oral contraceptives than bi or triphasic oral contraceptives [28]. We did not
control for the menstrual phases of the premenopausal females in the study for blood
draws and anthropometric measurements. This may account for some of the lack of
anthropometric reductions in some premenopausal females in the study.
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6. Age matching of the cohorts We did not match individual subjects by age between comparison groups, but the
mean ages of male and female groups from trained and untrained cohorts were similar.
Differences in age do not affect ADPN levels in females [29-31], but aging may increase
ADPN levels in normal-weight males over the age of 65 [32, 33]. However, males from
both trained and untrained cohorts that completed the 6-mo study and provided the
complete dataset were under the age of 65. Although the subjects were not age-matched,
the numerically small mean difference between the ages of completing male and female
groups is unlikely to significantly affect the comparability of our study groups either in
terms of ADPN levels or changes in ADPN levels.
7. Cohort size The sample sizes of our study groups are similar to the sample sizes of other
exercise-intervention study cohorts. But the specific reasons for the low sample size in
our study were –
(i)

Inclusion of only middle-aged, multi-year trained or untrained running
club members

(ii)

Exclusion of potential subjects on prescription medicines known to
influence ADPN levels

(iii)

Program attrition/drop out –

We experienced a lower drop out rate (36%) in untrained male subjects, than in
untrained female subjects (77%). We know anecdotally that repetitive stress injuries
disproportionately afflicted the untrained female subjects, but injuries did not account for
all who withdrew. We conjecture that untrained female subjects were especially

72

motivated to train in order to lose weight and that untrained male subjects were more
motivated to train in order to become more "fit" or "healthy". About 81% of the untrained
females that dropped out did so by half way through the study. We speculate that when
some of the overweight untrained females found little or no weight loss part-way into the
training program, they lost their primary incentive for training and withdrew from the
program.
The drop out rate was much lower in the trained subjects (males and females =
33.3%). The trained subjects withdrew from the study mainly due to repetitive stress
injuries, which are common among many full-distance marathon runners during longer
training runs [34].
8. Pro-inflammatory adipokines –
We did not measure pro-inflammatory cytokines, such as IL-6 or TNF- in
addition to FPI, FPG and ADPN. Hence, we can not connect increases in ADPN levels
observed in our study to reductions in pro-inflammatory adipokines. Out of many
adipokines, ADPN has closest structural resemblance to TNF-. An inverse correlation
has been reported in TNF- and ADPN levels [35]. Studies have reported a lack of
reduction in TNF- [36] and reductions in TNF- along with increases in ADPN levels
[37]. It is possible that increases in ADPN occur independently of reductions in other
pro-inflammatory adipokines.
9. Dietary control in the study –
Dietary intervention significantly increased ADPN levels, but not by 3-mo
aerobic exercise training in male rats [38]. The results of this study suggested that ADPN
levels may change differently by diet and exercise intervention. We did not regulate the
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dietary intake of our subjects. We now believe that controlling dietary intake in an
exercise intervention study would be advisable because having a similar diet among
subjects would help eliminate the possible influence of dietary variation on ADPN levels.
A controlled diet in an exercise-intervention study can be achieved by: 1) recruiting
subjects from the same baseline BMI group, e.g. overweight, obese, or normal-weight
subjects only and keeping total caloric intake constant between the study groups or 2) If
the cohort has a range of baseline BMI, the total number of calories can be assigned
based on a subject’s baseline BMI and physical activity while keeping the proportion of
major nutrients e.g. carbohydrates, proteins, fats, and fiber same in the subjects’ diet
during the period of the study.
10. Measurement of insulin resistance using HOMA-IR equation –
We calculated insulin resistance using the HOMA-IR equation, which is a
surrogate measure of insulin resistance [39]. Considering the long-term aerobic exercise
intervention of our study, it was difficult to use the gold standard, hyperinsulinemic
euglycemic clamp technique to measure insulin resistance of the subjects. The clamp
procedure is invasive, laborious, requires drawing multiple blood samples and has to be
conducted in a hospital setting. The insulin resistance values obtained by the HOMA-IR
method correlate with those obtained from the clamp technique and HOMA-IR method is
thus a reliable alternative to the clamp method of insulin resistance measurement [40].
Currently, tissue-specific insulin resistance is measured in three major organs: Liver,
skeletal muscle, and adipose tissue. While the HOMA-IR technique is reliable, it does not
provide information about organ-specific insulin resistance. It would be beneficial to
know if ADPN levels in our study increased due to improvement in insulin sensitivity in
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whole body or a specific organ. Hyperinsulinemic euglycemic clamp method in
combination with radio-labeled glucose, allows quantification of the organ-specific
contribution insulin resistance to the defect in whole-body insulin-mediated glucose
disposal [41].

Recommendations for Changes in Methodology
1. Measurement of Insulin levels –
Consider using an ELISA kit with a standard curve range similar to the physiological
FPI range (3-20 µU/ml). Ultrasensitive assay kits such as Insulin Ultrasensitive ELISA
(80-INSHUU-E01, Alpco Diagnostics, Salem, NH) offers the standard curve range
similar of the physiologic range of FPI (0.15 – 20 µU/ml). We used EZHI-14K (LINCO
Research, St. Charles, MO) ELISA kit to measure FPI levels. The standard curve of this
assay ranges from 2 – 200 µU/ml. As a result, this kit is not sensitive to measure
physiological FPI levels (3-20 µU/ml) in healthy subjects. Alpco Diagnostics’
ultrasensitive insulin kit was not available when we were conducting assays in year 2007.
2. Measuring insulin resistance –
Consider using the hyperinsulinemic euglycemic clamp technique to measure insulin
sensitivity in place of a surrogate measure of insulin resistance such as the HOMA-IR
score. Also consider employing glucose utilization technique to measure organ-specific
insulin resistance. We could not use the glucose clamp technique, as it requires dedicated
facility, which is not currently available at Loma Linda University.
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3. Measuring body fat –
Consider using Dual energy X-ray absorptiometry (DXA, formerly known as DEXA),
to measure body fat. This also is beneficial for knowing body fat composition and
changes in different body fat compartments. DXA measurements are expensive and time
consuming. In addition, the goal of the study was not to correlate increases in ADPN
through long-term aerobic exercise training to changes in body fat composition. Hence,
we used the BIA (bioelectric impedance) method of measurement of body fat.
4. Measurement of aerobic capacity –
Consider using VO2max measurement technique in place of “pace” of a subject to
measure the “fitness” or aerobic capacity of a subject. This measure will indicate if longterm aerobic training improved the subject’s aerobic capacity. However, measuring
VO2max requires an operational human performance laboratory which is not available at
Loma Linda University.

Future Studies
My hope is that the successes and challenges of the present research project will
open doors in new directions to further understand the connection between exercise and
adiponectin levels.
1. Increase the number of time points for sample acquisition between baseline and
the end of training protocol in a long-term aerobic training program. This will help in
understanding if there is a dose-response relationship between increase in exercise
training and ADPN levels.
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2. Continue fasting sample acquisition after end of the 6-mo aerobic training
program. This will help in understanding the time-course of changes in ADPN levels
after training distance is significantly reduced.
3. Acquire one-time, fasting blood samples from untrained and trained subjects and
separate the subjects based on ethnicity in a larger cross-sectional study. This will help in
understanding the influence of ethnicity on exercise-induced increases in ADPN levels.
4. Conduct an exercise-intervention study with controlled dietary intake (not
restricted). This will help in understanding if changes in ADPN are as a result of exercise
intervention alone and not due to dietary changes that might occur during a long-term
aerobic exercise-intervention.
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